|
Chester pregunto:
Remove card http://www.gb2gm.org/marconi-centre gabapentin 800 mg tablet Lantus will be going off-patent in the next couple of years but Sanofi has high hopes it can be replaced by an improved version, namely U300. Two Phase III studies were presented at the recent American Diabetes Association meeting in Chicago which demonstrated that U300 showed equivalent blood sugar control with fewer night-time low blood sugar events compared to Lantus. |
|
|
|
